BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35984439)

  • 1. Range of Risk Factor Levels, Risk Control, and Temporal Trends for Nephropathy and End-stage Kidney Disease in Patients With Type 1 and Type 2 Diabetes.
    Halminen J; Sattar N; Rawshani A; Eliasson B; Eeg-Olofsson K; Bhatt DL; Rawshani A
    Diabetes Care; 2022 Oct; 45(10):2326-2335. PubMed ID: 35984439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Incidence of ESKD in People With Type 1 and Type 2 Diabetes in Australia, 2002-2013.
    Koye DN; Magliano DJ; Reid CM; Pavkov ME; Chadban SJ; McDonald SP; Polkinghorne KR; White S; Paul C; Shaw JE
    Am J Kidney Dis; 2019 Mar; 73(3):300-308. PubMed ID: 30579709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney failure risk in type 1 vs. type 2 childhood-onset diabetes mellitus.
    Pleniceanu O; Twig G; Tzur D; Gruber N; Stern-Zimmer M; Afek A; Erlich T; Keinan-Boker L; Skorecki K; Calderon-Margalit R; Vivante A
    Pediatr Nephrol; 2021 Feb; 36(2):333-340. PubMed ID: 32761484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk for diabetic nephropathy is low in young adults in a 17-year follow-up from the Diabetes Incidence Study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors.
    Svensson MK; Tyrberg M; Nyström L; Arnqvist HJ; Bolinder J; Östman J; Gudbjörnsdottir S; Landin-Olsson M; Eriksson JW
    Diabetes Metab Res Rev; 2015 Feb; 31(2):138-46. PubMed ID: 25044633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study.
    Sattar N; McMurray J; Borén J; Rawshani A; Omerovic E; Berg N; Halminen J; Skoglund K; Eliasson B; Gerstein HC; McGuire DK; Bhatt D; Rawshani A
    Circulation; 2023 Jun; 147(25):1872-1886. PubMed ID: 37154040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microscopic hematuria is a risk factor for end-stage kidney disease in patients with biopsy-proven diabetic nephropathy.
    Okada S; Samejima KI; Matsui M; Morimoto K; Furuyama R; Tanabe K; Eriguchi M; Akai Y; Saito Y; Tsuruya K
    BMJ Open Diabetes Res Care; 2020 Nov; 8(2):. PubMed ID: 33148691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal histology in diabetic nephropathy predicts progression to end-stage kidney disease but not the rate of renal function decline.
    Misra PS; Szeto SG; Krizova A; Gilbert RE; Yuen DA
    BMC Nephrol; 2020 Jul; 21(1):285. PubMed ID: 32682403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk.
    Lim WH; Johnson DW; Hawley C; Lok C; Polkinghorne KR; Roberts MA; Boudville N; Wong G
    Med J Aust; 2018 Nov; 209(10):440-446. PubMed ID: 30332936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association Between Age of Onset of Type 2 Diabetes and the Long-term Risk of End-Stage Kidney Disease: A National Registry Study.
    Morton JI; Liew D; McDonald SP; Shaw JE; Magliano DJ
    Diabetes Care; 2020 Aug; 43(8):1788-1795. PubMed ID: 32540924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan.
    Hollenberg NK
    Curr Hypertens Rep; 2001 Jun; 3(3):177. PubMed ID: 11421227
    [No Abstract]   [Full Text] [Related]  

  • 11. The Incidence of End-Stage Renal Disease in the Diabetic (Compared to the Non-Diabetic) Population: A Systematic Review.
    Narres M; Claessen H; Droste S; Kvitkina T; Koch M; Kuss O; Icks A
    PLoS One; 2016; 11(1):e0147329. PubMed ID: 26812415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of glycated hemoglobin with mortality and ESKD among persons with diabetes and chronic kidney disease.
    Limkunakul C; de Boer IH; Kestenbaum BR; Himmelfarb J; Ikizler TA; Robinson-Cohen C
    J Diabetes Complications; 2019 Apr; 33(4):296-301. PubMed ID: 30795915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-coronary peripheral arterial complications in people with type 2 diabetes: a Swedish retrospective cohort study.
    Rawshani A; Eliasson B; Boren J; Sattar N; Bhatt D; El-Khalili L; Nordanstig J; Avdic T; Beckman JA; Gerstein HC; McGuire DK; Omerovic E; Rawshani A
    Lancet Reg Health Eur; 2024 Apr; 39():100888. PubMed ID: 38803635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Related factors of diabetic nephropathy in patients with type 1 diabetes mellitus].
    Zhou XW; Jiang J; Ren W; Fei YY; Peng L; Jiang JL; Lan L; Ye SD
    Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(30):2403-2406. PubMed ID: 30138984
    [No Abstract]   [Full Text] [Related]  

  • 15. Sex differences in risk factors for end-stage kidney disease and death in type 2 diabetes: A retrospective cohort study.
    Oshima M; Iwata Y; Toyama T; Kitajima S; Hara A; Sakai N; Shimizu M; Furuichi K; Haneda M; Babazono T; Yokoyama H; Iseki K; Araki S; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Makino H; Wada T
    J Diabetes; 2023 Mar; 15(3):246-254. PubMed ID: 36785912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinopathy progression and the risk of end-stage kidney disease: results from a longitudinal Japanese cohort of 232 patients with type 2 diabetes and biopsy-proven diabetic kidney disease.
    Yamanouchi M; Mori M; Hoshino J; Kinowaki K; Fujii T; Ohashi K; Furuichi K; Wada T; Ubara Y
    BMJ Open Diabetes Res Care; 2019; 7(1):e000726. PubMed ID: 31798893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
    Agardh CD; Agardh E; Torffvit O
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher incidence of cardiovascular-kidney complications in Chinese with youth-onset type 2 diabetes versus youth-onset type 1 diabetes attenuated by control of cardio-metabolic risk factors: A population-based prospective cohort study in Hong Kong.
    Fan Y; Lau ESH; Wu H; Yang A; Chow E; Kong APS; Ma RCW; Chan JCN; Luk AOY
    Diabetes Res Clin Pract; 2023 Aug; 202():110728. PubMed ID: 37217017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HbA
    Lind M; Pivodic A; Svensson AM; Ólafsdóttir AF; Wedel H; Ludvigsson J
    BMJ; 2019 Aug; 366():l4894. PubMed ID: 31462492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extreme Levels of HbA1c Increase Incident ESRD Risk in Chinese Patients with Type 2 Diabetes: Competing Risk Analysis in National Cohort of Taiwan Diabetes Study.
    Liao LN; Li CI; Liu CS; Huang CC; Lin WY; Chiang JH; Lin CC; Li TC
    PLoS One; 2015; 10(6):e0130828. PubMed ID: 26098901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.